Health at a Glance 2017: OECD Indicators

Annual new drug approvals (NDAs) per billion USD pharmaceutical business expenditure on R&D in the United States, inflation-adjusted

DOI:https://dx.doi.org/10.1787/health_glance-2017-graph186-en



Linking

Link to this publication:
Link to this publication with cover:
Link to this page:

Embedding

800
x
600
550
x
700
AUTO
SIZE
Custom:
Width:
Height: